135 related articles for article (PubMed ID: 15604787)
1. High level production of bovine angiogenin in E. coli by an efficient refolding procedure.
Jang SH; Kang DK; Chang SI; Scheraga HA; Shin HC
Biotechnol Lett; 2004 Oct; 26(19):1501-4. PubMed ID: 15604787
[TBL] [Abstract][Full Text] [Related]
2. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of three members of the murine angiogenin family in Escherichia coli and purification of the recombinant proteins.
Holloway DE; Hares MC; Shapiro R; Subramanian V; Acharya KR
Protein Expr Purif; 2001 Jul; 22(2):307-17. PubMed ID: 11437607
[TBL] [Abstract][Full Text] [Related]
4. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
Tan H; Dan G; Gong H; Cao L
Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
[TBL] [Abstract][Full Text] [Related]
5. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells.
Jimi S; Ito K; Kohno K; Ono M; Kuwano M; Itagaki Y; Ishikawa H
Biochem Biophys Res Commun; 1995 Jun; 211(2):476-83. PubMed ID: 7540839
[TBL] [Abstract][Full Text] [Related]
6. Direct refolding of inclusion bodies using reversed micelles.
Sakono M; Kawashima YM; Ichinose H; Maruyama T; Kamiya N; Goto M
Biotechnol Prog; 2004; 20(6):1783-7. PubMed ID: 15575712
[TBL] [Abstract][Full Text] [Related]
7. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
Cabrita LD; Bottomley SP
Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification and characterization of recombinant human angiogenin in Pichia pastoris.
Xia WR; Fu WL; Cai L; Cai X; Wang YY; Zou MJ; Xu DG
Biosci Biotechnol Biochem; 2012; 76(7):1384-8. PubMed ID: 22785483
[TBL] [Abstract][Full Text] [Related]
9. Expression of biologically active kringle 5 domain of human plasminogen in Escherichia coli.
Zhang HX; Fang L; Cheng J; Wei Z; Hua ZC
Prep Biochem Biotechnol; 2005; 35(1):17-27. PubMed ID: 15704494
[TBL] [Abstract][Full Text] [Related]
10. Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in
Hashemzadeh MS; Mohammadi M; Ghaleh HEG; Sharti M; Choopani A; Panda AK
Protein Pept Lett; 2021; 28(2):122-130. PubMed ID: 32729411
[TBL] [Abstract][Full Text] [Related]
11. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
[TBL] [Abstract][Full Text] [Related]
12. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
13. Strategies for boosting the accumulation of correctly folded recombinant proteins expressed in Escherichia coli.
de Marco A
Methods Mol Biol; 2011; 752():1-15. PubMed ID: 21713627
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification, and bioactivity of human tumstatin from Escherichia coli.
Gu Q; Zhang T; Luo J; Wang F
Protein Expr Purif; 2006 Jun; 47(2):461-6. PubMed ID: 16503164
[TBL] [Abstract][Full Text] [Related]
15. A simplified bioprocess for human alpha-fetoprotein production from inclusion bodies.
Leong SS; Middelberg AP
Biotechnol Bioeng; 2007 May; 97(1):99-117. PubMed ID: 17115449
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of recombinant plasminogen kringle 1-3 to angiogenin inhibits angiogenin-induced angiogenesis in the chick embryo CAM.
Youn MR; Park MH; Choi CK; Ahn BC; Kim HY; Kang SS; Hong YK; Joe YA; Kim JS; You WK; Lee HS; Chung SI; Chang SI
Biochem Biophys Res Commun; 2006 May; 343(3):917-23. PubMed ID: 16564503
[TBL] [Abstract][Full Text] [Related]
17. Expression of the hAng gene in Escherichia coli; isolation and characterization of human recombinant Ser-(-1) angiogenin.
Lapidus AL; Mochul'skii AV; Podkovyrov SM; Lebedeva MI; Antipin AA; Izotova LS; Zagnit'ko OP; Komolova GS; Klesov AA; Veiko VP
Biomed Sci; 1990; 1(6):597-604. PubMed ID: 2132944
[TBL] [Abstract][Full Text] [Related]
18. Refolding and purification of Apo2l/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.
Shen YL; Xia XX; Zhang Y; Liu JW; Wei DZ; Yang SL
Biotechnol Lett; 2003 Dec; 25(24):2097-101. PubMed ID: 14969416
[TBL] [Abstract][Full Text] [Related]
19. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
Kang H; Sun AY; Shen YL; Wei DZ
Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
[TBL] [Abstract][Full Text] [Related]
20. Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure.
Fradkin AH; Boand CS; Eisenberg SP; Rosendahl MS; Randolph TW
Biotechnol Prog; 2010; 26(3):743-9. PubMed ID: 20196161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
